jm500927d_si_001.pdf (1.18 MB)

Synthesis, Antitumor Activity, and Mechanism of Action of Benzo[b]chromeno[6,5‑g][1,8]naphthyridin-7-one Analogs of Acronycine

Download (1.18 MB)
journal contribution
posted on 26.12.2014, 00:00 by Wen Tian, Rodrigue Yougnia, Sabine Depauw, Amélie Lansiaux, Marie-Hélène David-Cordonnier, Bruno Pfeiffer, Laurence Kraus-Berthier, Stéphane Léonce, Alain Pierré, Hanh Dufat, Sylvie Michel
A series of 6-methoxy-3,3,14-trimethyl-3,14-dihydro-7H-benzo­[b]­chromeno­[6,5-g]­[1,8]­naphthyridin-7-one (4), 13-aza derivatives of benzo­[b]­acronycine, the isomeric 5-methoxy-2,2,13-trimethyl-2,13-dihydro-6H-benzo­[b]­chromeno­[7,6-g]­[1,8]­naphthyridin-6-one (5), and related cis-diols mono- and diesters were designed and synthesized. Their in vitro and in vivo biological activities were evaluated. As previously observed in the acronycine series, esters were the most potent derivatives exhibiting submicromolar activities; among them monoesters are particularly active. Racemic diacetate 21 showed a strong activity against KB-3-1 cell lines and was selected for in vivo evaluation and proved to be active, inhibiting tumor growth by more than 80%. After separation of the two enantiomers, compounds 21a and 21b were also evaluated against C38 colon adenocarcinoma; their activities were found to be significantly different.